Durham, NC, United States of America

Don Harvan


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Don Harvan: Innovator in Biomarkers for Neurological Disorders

Introduction

Don Harvan is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of medical research, particularly in the development of biomarkers for neurological disorders. With a total of 2 patents, his work focuses on improving diagnosis and treatment methods for conditions such as amyotrophic lateral sclerosis (ALS) and depression.

Latest Patents

Harvan's latest patents include "Biomarkers for amyotrophic lateral sclerosis and methods using the same." This invention provides various biomarkers for ALS and outlines methods for diagnosing the condition, determining predisposition, monitoring progression, assessing treatment efficacy, and screening compositions for activity in modulating ALS biomarkers. His second patent, "Biomarkers for depression and methods using the same," offers similar advancements for depression, including methods for diagnosis, monitoring, and treatment.

Career Highlights

Throughout his career, Don Harvan has worked with reputable organizations such as Metabolon, Inc. and Massachusetts General Hospital Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Harvan's notable coworkers include Lisa A Paige and Matthew W Mitchell. Their collaborative efforts have furthered the understanding and treatment of neurological disorders.

Conclusion

Don Harvan's innovative work in the field of biomarkers has the potential to transform the diagnosis and treatment of ALS and depression. His contributions are invaluable to medical research and the improvement of patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…